One of the sources of uncertainty with the BTX 1801 product was whether the preliminary results for pig skin models could be replicate on human skin. Final proof is in the stage 2a trial but these results de-risk BOT quite a bit.
- Forums
- ASX - By Stock
- BOT
- Ann: New Antimicrobial Data and Conference Presentation
Ann: New Antimicrobial Data and Conference Presentation, page-13
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $581.5M |
Open | High | Low | Value | Volume |
32.5¢ | 32.5¢ | 31.5¢ | $1.940M | 6.061M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 470483 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 33000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 467608 | 0.315 |
27 | 806928 | 0.310 |
11 | 241226 | 0.305 |
31 | 495096 | 0.300 |
6 | 120637 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 33000 | 1 |
0.325 | 176270 | 4 |
0.330 | 80538 | 3 |
0.335 | 285000 | 3 |
0.340 | 834146 | 6 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online